Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Oct 17;193(Supplement_2):ii35-ii46.
doi: 10.1093/ejendo/lvaf066.

EndoCompass project: research roadmap for endocrine causes and consequences of cancer

Jason S Carroll  1 , Frederic Castinetti  2   3 , Cecilia Follin  4 , Raul M Luque  5 , Annemarie A Verrijn Stuart  6 , Aleksander Giwercman  7 , Simona Grozinsky-Glasberg  8 , Csilla Krausz  9 , Stavroula A Paschou  10 , Robin Peeters  11 , Carolina R C Pieterman  12 , Pauline Romanet  13 , Juan M Jiménez-Vacas  14 , Hanneke M van Santen  6   15 , Karin Zibar Tomšic  16
Affiliations

EndoCompass project: research roadmap for endocrine causes and consequences of cancer

Jason S Carroll et al. Eur J Endocrinol. .

Abstract

Background: Endocrine science remains underrepresented in European Union research programmes despite the fundamental role of hormone health in human wellbeing. Analysis of the CORDIS database reveals a persistent gap between the societal impact of endocrine disorders and their research prioritisation. At national funding level, endocrine societies report limited or little attention of national research funding towards endocrinology. The EndoCompass project-a joint initiative between the European Society of Endocrinology and the European Society of Paediatric Endocrinology-aimed to identify and promote strategic research priorities in endocrine science to address critical hormone-related health challenges.

Methods: Research priorities were established through comprehensive analysis of the EU CORDIS database covering the Horizon 2020 framework period (2014-2020). Expert consultation was conducted to identify key research priorities, followed by broader stakeholder engagement including society members and patient advocacy groups.

Results: Research priorities encompass re-evaluation of progestins in breast cancer treatment; strategies to disrupt AR signalling in prostate cancer; surveillance for endocrine sequelae in childhood cancer survivors; understanding genotoxic effects on fertility; and management of checkpoint inhibitor endocrinopathies and familial cancer syndromes. Emphasis is placed on precision medicine and metabolic factors in cancer.

Conclusions: This component of the EndoCompass project provides an evidence-based roadmap for strategic research investment. This framework identifies crucial investigation areas into cancer-endocrine pathophysiology, prevention, and treatment strategies, ultimately aimed at reducing the burden of these disorders on individuals and society. The findings support the broader EndoCompass objective of aligning research funding with areas of highest potential impact in endocrine health.

Keywords: EndoCompass; cancer syndrome; endocrine-related cancer; funding; roadmap.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared.